Summary:
HPV and COVID-19 Vaccine Study Opportunity for Ages 9 To 11
HPV, or human papillomavirus, is a common virus that can cause certain cancers in men and women. A 2-dose HPV vaccination is accepted and recommended for children between 9 to 14 years of age. The V503-076 clinical research study is designed to learn if the HPV vaccine works well when given at the same time as a COVID-19 vaccine in children ages 9 to 11 years old. The vaccines in this study are investigational.
Has your 9- to 11-year-old not yet received a COVID-19 or HPV vaccination? Consider a cost-free clinical research study to get them a COVID-19 vaccine with an HPV vaccine.
Eligible Children for Participation:
- Are ages 9 to 11 years old
- Have not yet received any doses of a COVID-19 vaccination or an HPV vaccination
- Have not had COVID-19 in the past 90 days or history of HPV infection
- Have a parent or legal guardian who is willing and able to attend all study visits
There are other qualifications needed for enrollment in this study. Study staff will discuss them with you after you apply for participation.